Labcorp (NYSE: LH), a US-based life sciences company, announced, its cash dividend on Friday.
The company has declared a cash dividend of USD0.72 per share of common stock.
The dividend will be paid to shareholders of record at 27 February 2024 on 13 March 2024.
Labcorp is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. It provides insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities.
Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion
ANI Pharmaceuticals announces buyout of royalty obligation for ILUVIEN and YUTIQ
Sirum collaborates with Governor Wes Moore to expand medication access across Maryland
West Pharmaceutical Services announces Q2 dividend
Perrigo increases quarterly dividend
AbbVie announces quarterly cash dividend
hVIVO acquires German Clinical Research Units for EUR10m; Targets earnings growth by 2026
Poxel to receive royalties and sales-based payment from Sumitomo Pharma
ReciBioPharm secures grant to expand RNA manufacturing in LMICs
CVS Health to pays common stock quarterly dividend of USD0.665 per share
TC BioPharm receives shareholders' approval for 25% stock dividend
USANA Health Sciences acquires controlling stake in Hiya Health for USD205m